Kambiz Eftekhari

Kambiz Eftekhari

Auto-generated profile, based on publicly available information

Kambiz Eftekhari

Department of Pediatric Gastroenterology, Bahrami Children’s Hospital, School of Medicine, Pediatric Gastroenterology and Hepatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Infectious Diseases
Verified
Journal Article
Closed access
MAMojtaba Kamali Aghdam
Mojtaba Kamali Aghdam
NJNahid Jafari
Nahid Jafari
KEKambiz Eftekhari
Kambiz Eftekhari
Introduction: Novel coronavirus or coronavirus disease (COVID-19) can affect all age groups. The clinical course of the disease in children and infants is milder than in adults. It should be noted that, although typical symptoms may be present in children, non-specific symptoms could be noted in the neonate. The disease is rare in the neonate, so, its suspicion in this group can help to make a quick diagnose.Case report: A 15-day-old neonate was admitted with fever, lethargy, cutaneous mottling, and respiratory distress without cough. His mother had symptoms of Novel coronavirus. So Reverse-Transcription Polymerase Chain Reaction (RT-PCR) assay was done for the neonate and showed to be positive. The newborn was isolated and subjected to supportive care. Antibiotic and antiviral treatment was initiated. Eventually, the baby was discharged in good general condition.Conclusion: When a newborn presents with non-specific symptoms of infection with an added history of COVID-19 in his/her parents, it indicates the need for PCR testing for Novel coronavirus.

9 April 2014 in International Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SSSara Sadeghzadeh
Sara Sadeghzadeh
ARA. Rabieefar
A. Rabieefar
PKP. Khoshnevisasl
P. Khoshnevisasl
NMN. Mousavinasab
N. Mousavinasab
KEK. Eftekhari
K. Eftekhari
Background. Inconsistent data exist about the role of probiotics in the treatment of constipated children. The aim of this study was to investigate the effectiveness of probiotics in childhood constipation. Materials and Methods. In this placebo controlled trial, fifty-six children aged 4–12 years with constipation received randomly lactulose plus Protexin or lactulose plus placebo daily for four weeks. Stool frequency and consistency, abdominal pain, fecal incontinence, and weight gain were studied at the beginning, after the first week, and at the end of the 4th week in both groups. Results. Forty-eight patients completed the study. At the end of the fourth week, the frequency and consistency of defecation improved significantly ( and , resp.). At the end of the first week, fecal incontinence and abdominal pain improved significantly in intervention group ( and , resp.) but, at the end of the fourth week, this difference was not significant ( and , resp.). A significant weight gain was observed at the end of the 1st week in the treatment group. Conclusion. This study showed that probiotics had a positive role in increasing the frequency and improving the consistency at the end of 4th week.

23 December 2015 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
KEKambiz Eftekhari
Kambiz Eftekhari
ZVZahra Vahedi
Zahra Vahedi
MAMojtaba Kamali Aghdam
Mojtaba Kamali Aghdam
DDDiana Noemi Diaz
Diana Noemi Diaz
Background: Functional abdominal pain (FAP) is one of the most common diseases, and large percentages of children suffer from it. Objectives: The purpose of the study was to evaluate the effect of Lactobacillus reuteri in treatment of children with functional abdominal pain. Patients and Methods: This study was a randomized double-blind placebo-controlled trial. Children aged 4 to 16 years with chronic functional abdominal pain (based on Rome III criteria) were enrolled in the study. They were randomly divided into two groups, one receiving probiotic and the other placebo. Results: Forty children received probiotic and forty others placebo. There were no significant differences in age, weight, sex, location of pain, associated symptoms, frequency and intensity of pain between the groups. The severity and frequency of abdominal pain in the first month compared to baseline was significantly less and at the end of the second month, there was no significant difference between both groups compared to the end of the first month. Conclusions: This study showed that the severity of pain was significantly reduced in both groups. There was no significant difference in pain scores between them. The effect of probiotic and placebo can probably be attributed to psychological effect of the drugs. Keywords: Lactobacillus reuteri ; Functional Abdominal Pain; Children

AMArmen Malekiantaghi
Armen Malekiantaghi
KAKosar AsnaAshari
Kosar AsnaAshari
HSHosein Shabani-Mirzaee
Hosein Shabani-Mirzaee
MVMohsen Vigeh
Mohsen Vigeh
MSMohsen Sadatinezhad
Mohsen Sadatinezhad
KEKambiz Eftekhari
Kambiz Eftekhari
Background: Malnutrition is a determining factor of pediatric mortality and morbidity, especially in low and middle-income countries. Hospitalized children are at a higher risk of malnutrition. Several malnutrition screening tools have been used, among which STAMP, PYMS, and STRONGkids are valid tools with high sensitivity and specificity. The aim of this study was to compare these screening tools to find the best ones in identifying the risk of malnutrition in hospitalized children. Methods: This is a cross-sectional study performed on hospitalized children aged 1 to 16 years. The questionnaires of PYMS, STAMP, STRONGkids malnutrition risk assessment tools were filled. The weight for height and BMI for age Z-scores were calculated. The data were analyzed by SPSS. Sensitivity, specificity, positive predictive value, and negative predictive values of the risk scores based on weight for height and BMI for age Z-scores were calculated. Results: Ninety-three patients with a mean age of 5.53 ± 3.9 years were included. The frequency of malnutrition was reported as 26% and 39% according to weight for height and BMI for age Z-scores, respectively. A significant relationship was found between PYMS and Weight for height Z-score (P-value < 0.001), and BMI for age Z-score (P-value < 0.001). Moreover, STRONGkids was found to be associated with weight for height Z-score (P-value: 0.017). Conclusion: The PYMS is a practical and beneficial tool in early identifying the risk of severe malnutrition in hospitalized patients. It is a suitable method for patients in our settings.

1 January 2023 in Pediatric Endocrinology Diabetes and Metabolism
Verified
Journal Article
Open access
HSHosein Shabani-Mirzaee
Hosein Shabani-Mirzaee
ZHZahra Haghshenas
Zahra Haghshenas
AMArmen Malekiantaghi
Armen Malekiantaghi
MVMohsen Vigeh
Mohsen Vigeh
FMFazeleh Mahdavi
Fazeleh Mahdavi
KEKambiz Eftekhari
Kambiz Eftekhari
Introduction Proper control of blood glucose in children with type 1 diabetes has a direct effect on their metabolism and quality of life by reducing the risk of complications. The use of probiotics may have a beneficial effect on glucose levels. Purpose The aim of this study was to evaluate...

4 July 2018 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
PAPedram Ataee
Pedram Ataee
MZMasoumeh Zoghali
Masoumeh Zoghali
BNBahram Nikkhoo
Bahram Nikkhoo
EGEbrahim Ghaderi
Ebrahim Ghaderi
MMMajid Mansouri
Majid Mansouri
KEKambiz Eftekhari
Kambiz Eftekhari
Background: Food allergy is an abnormal immunologic reaction to food proteins. During infancy, allergic colitis presents with bloody stool of a healthy child. calprotectin is released into the intestinal lumen by macrophages and neutrophils and is a reliable and non-invasive biomarker for evaluating inflammation of the digestive system. Objectives: This study evaluated the changes of fecal calprotectin after modification of mother’s diet, on breastfed infants with food allergy. Methods: This study was conducted on 29 infants less than one year old with allergic colitis, referred to the Besat hospital of Sanandaj (Iran) from 2013 to 2014. All infants were breast-fed. The fecal calprotectin levels were measured on admission; two and six weeks after starting hypo-allergenic diet for mothers and its levels were correlated with clinical findings. Results: With the onset of maternal hypoallergenic diet, clinical symptoms showed a statistically significant reduction (P < 0.05). The fecal calprotectin levels decreased during the study. Despite the declining trend of the fecal calprotectin levels, there was no statistical correlation between clinical and laboratory findings (P = 0.741 and P = 0.284). Conclusions: This study showed that changes on fecal calprotectin levels are not a good indicator for assessment of clinical improvement in food allergy. There was no statistically significant difference between the fecal calprotectin levels on admission, two weeks and six weeks after the intervention. Keywords: Breast Feeding; Calprotectin; Colitis; Diet; Infant